twitter Tweet

New questions about the tradeoffs in ‘accelerated’ cancer drug studies

Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X